Apeloa Pharmaceutical Co.,Ltd (000739.SZ)
CNY 13.85
(0.0%)
CNY 13.85
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.79 Billion CNY | 5.22% |
| 2022 | 1.46 Billion CNY | -1.27% |
| 2021 | 1.5 Billion CNY | 20.72% |
| 2020 | 1.27 Billion CNY | 24.42% |
| 2019 | 1.01 Billion CNY | 20.76% |
| 2018 | 819.66 Million CNY | 14.7% |
| 2017 | 671.24 Million CNY | 0.6% |
| 2016 | 639.96 Million CNY | 16.12% |
| 2015 | 546.23 Million CNY | -11.69% |
| 2014 | 637.7 Million CNY | 35.99% |
| 2013 | 445.5 Million CNY | 9.87% |
| 2012 | 388.09 Million CNY | 204.29% |
| 2011 | 328.38 Million CNY | -3.26% |
| 2010 | 130.37 Million CNY | -1.57% |
| 2009 | 156.22 Million CNY | 24.82% |
| 2008 | 128.63 Million CNY | 10.86% |
| 2007 | 121.21 Million CNY | -16.83% |
| 2006 | 152.21 Million CNY | 23.48% |
| 2005 | 119.63 Million CNY | 14.81% |
| 2004 | 104.19 Million CNY | 7.32% |
| 2003 | 97.08 Million CNY | 2.35% |
| 2002 | 94.85 Million CNY | 839.62% |
| 2001 | -12.82 Million CNY | -204.89% |
| 2000 | 7.51 Million CNY | 158.33% |
| 1999 | 4.8 Million CNY | -77.3% |
| 1998 | 17.63 Million CNY | -17.25% |
| 1997 | 25.19 Million CNY | 30.74% |
| 1996 | 19.27 Million CNY | 19.06% |
| 1995 | 16.18 Million CNY | 37.19% |
| 1994 | 11.8 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 503.44 Million CNY | 29.55% |
| 2024 Q3 | 288.56 Million CNY | -50.87% |
| 2024 Q1 | 364.09 Million CNY | 32.71% |
| 2023 Q1 | 358.91 Million CNY | 23.67% |
| 2023 Q3 | 321.49 Million CNY | -25.77% |
| 2023 Q2 | 433.09 Million CNY | 20.67% |
| 2023 Q4 | 260.52 Million CNY | -18.96% |
| 2023 FY | - CNY | 5.22% |
| 2022 Q3 | 270.33 Million CNY | -35.59% |
| 2022 Q1 | 189.96 Million CNY | -29.35% |
| 2022 Q2 | 419.71 Million CNY | 120.94% |
| 2022 FY | - CNY | -1.27% |
| 2022 Q4 | 290.21 Million CNY | 7.35% |
| 2021 Q4 | 268.88 Million CNY | 3.11% |
| 2021 FY | - CNY | 20.72% |
| 2021 Q2 | 426.58 Million CNY | 61.11% |
| 2021 Q1 | 264.78 Million CNY | 17.88% |
| 2021 Q3 | 260.76 Million CNY | -38.87% |
| 2020 FY | - CNY | 24.42% |
| 2020 Q3 | 215.94 Million CNY | -38.33% |
| 2020 Q2 | 350.15 Million CNY | 97.69% |
| 2020 Q4 | 224.62 Million CNY | 4.02% |
| 2020 Q1 | 177.12 Million CNY | 96.36% |
| 2019 FY | - CNY | 20.76% |
| 2019 Q1 | 144.59 Million CNY | -31.92% |
| 2019 Q2 | 209.61 Million CNY | 44.96% |
| 2019 Q3 | 220.61 Million CNY | 5.25% |
| 2019 Q4 | 90.2 Million CNY | -59.11% |
| 2018 Q3 | 100.39 Million CNY | -32.63% |
| 2018 FY | - CNY | 14.7% |
| 2018 Q4 | 212.39 Million CNY | 111.56% |
| 2018 Q2 | 149.01 Million CNY | 27.6% |
| 2018 Q1 | 116.78 Million CNY | -32.3% |
| 2017 FY | - CNY | 0.6% |
| 2017 Q1 | 91.04 Million CNY | -60.31% |
| 2017 Q3 | 43.96 Million CNY | -62.01% |
| 2017 Q4 | 172.52 Million CNY | 292.39% |
| 2017 Q2 | 115.72 Million CNY | 27.1% |
| 2016 Q4 | 229.4 Million CNY | 191.75% |
| 2016 FY | - CNY | 16.12% |
| 2016 Q1 | 62.58 Million CNY | -39.63% |
| 2016 Q2 | 114.36 Million CNY | 82.74% |
| 2016 Q3 | 78.63 Million CNY | -31.25% |
| 2015 Q2 | 144.33 Million CNY | 129.34% |
| 2015 Q1 | 62.93 Million CNY | -71.19% |
| 2015 Q4 | 103.67 Million CNY | -5.51% |
| 2015 FY | - CNY | -11.69% |
| 2015 Q3 | 109.71 Million CNY | -23.98% |
| 2014 Q4 | 218.47 Million CNY | 207.65% |
| 2014 Q3 | 71.01 Million CNY | -70.03% |
| 2014 Q2 | 236.92 Million CNY | 272.39% |
| 2014 Q1 | 63.62 Million CNY | -45.96% |
| 2014 FY | - CNY | 35.99% |
| 2013 Q3 | 65.89 Million CNY | -35.82% |
| 2013 FY | - CNY | 9.87% |
| 2013 Q1 | 44.03 Million CNY | -79.29% |
| 2013 Q2 | 102.66 Million CNY | 133.13% |
| 2013 Q4 | 117.72 Million CNY | 78.67% |
| 2012 Q3 | 27.38 Million CNY | -37.58% |
| 2012 Q1 | 15.39 Million CNY | -64.41% |
| 2012 Q4 | 212.61 Million CNY | 676.3% |
| 2012 Q2 | 43.87 Million CNY | 184.95% |
| 2012 FY | - CNY | 204.29% |
| 2011 FY | - CNY | -3.26% |
| 2011 Q3 | 11.59 Million CNY | 677.75% |
| 2011 Q4 | 43.26 Million CNY | 273.05% |
| 2011 Q2 | -2 Million CNY | -117.07% |
| 2011 Q1 | 11.75 Million CNY | -48.4% |
| 2010 FY | - CNY | -1.57% |
| 2010 Q4 | 22.78 Million CNY | 2.94% |
| 2010 Q3 | 22.13 Million CNY | 11.42% |
| 2010 Q2 | 19.86 Million CNY | 41.69% |
| 2010 Q1 | 14.02 Million CNY | -47.08% |
| 2009 Q2 | 27.61 Million CNY | 96.16% |
| 2009 FY | - CNY | 24.82% |
| 2009 Q4 | 26.49 Million CNY | 34.48% |
| 2009 Q3 | 19.69 Million CNY | -28.67% |
| 2009 Q1 | 14.07 Million CNY | 81.18% |
| 2008 Q1 | 14.25 Million CNY | -4.07% |
| 2008 FY | - CNY | 10.86% |
| 2008 Q4 | 7.77 Million CNY | -67.73% |
| 2008 Q3 | 24.08 Million CNY | 0.97% |
| 2008 Q2 | 23.84 Million CNY | 67.32% |
| 2007 Q4 | 14.85 Million CNY | -14.0% |
| 2007 FY | - CNY | -16.83% |
| 2007 Q3 | 17.27 Million CNY | 19.26% |
| 2007 Q2 | 14.48 Million CNY | -29.67% |
| 2007 Q1 | 20.59 Million CNY | -57.51% |
| 2006 Q2 | 40.48 Million CNY | 35.94% |
| 2006 FY | - CNY | 23.48% |
| 2006 Q4 | 48.47 Million CNY | 54.35% |
| 2006 Q3 | 31.4 Million CNY | -22.42% |
| 2006 Q1 | 29.77 Million CNY | -15.12% |
| 2005 Q2 | 21.91 Million CNY | 50.0% |
| 2005 Q4 | 35.08 Million CNY | 15.34% |
| 2005 Q3 | 30.41 Million CNY | 38.78% |
| 2005 Q1 | 14.61 Million CNY | -59.16% |
| 2005 FY | - CNY | 14.81% |
| 2004 Q2 | 23.02 Million CNY | 97.49% |
| 2004 Q4 | 35.77 Million CNY | 108.45% |
| 2004 Q1 | 11.65 Million CNY | -39.61% |
| 2004 FY | - CNY | 7.32% |
| 2004 Q3 | 17.16 Million CNY | -25.44% |
| 2003 Q1 | 19.56 Million CNY | 18.8% |
| 2003 FY | - CNY | 2.35% |
| 2003 Q3 | 6.3 Million CNY | -58.79% |
| 2003 Q4 | 19.3 Million CNY | 205.94% |
| 2003 Q2 | 15.3 Million CNY | -21.75% |
| 2002 Q4 | 16.46 Million CNY | 21.01% |
| 2002 FY | - CNY | 839.62% |
| 2002 Q3 | 13.6 Million CNY | -75.97% |
| 2002 Q2 | 56.62 Million CNY | 395.93% |
| 2002 Q1 | -19.13 Million CNY | -339.05% |
| 2001 Q4 | 8 Million CNY | 136.74% |
| 2001 Q3 | -21.78 Million CNY | 0.0% |
| 2001 FY | - CNY | -204.89% |
| 2000 FY | - CNY | 158.33% |
| 1999 FY | - CNY | -77.3% |
| 1998 FY | - CNY | -17.25% |
| 1997 FY | - CNY | 30.74% |
| 1996 FY | - CNY | 19.06% |
| 1995 FY | - CNY | 37.19% |
| 1994 FY | - CNY | 0.0% |